ArticleCrohn's & colitis 3602020

Patients' Willingness and Perspectives Toward Chimeric Antigen Receptor T-Regulatory Cell Therapy for Inflammatory Bowel Diseases.

Jens Vent-Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.